Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Abhijeet Kumar
Associate Professor, Medicine - (Clinical Scholar Track)
Medicine
Overview
Research
More
Collaboration
(26)
Carolyn Lane
Mutual work: 2 Grants
Collaboration Details
Jennifer Segar
Mutual work: 7 Grants
Collaboration Details
Ricklie Julian
Mutual work: 7 Grants
Collaboration Details
Ahmad Iftikhar
Mutual work: 1 Publication
Collaboration Details
Emmanuel Katsanis
Mutual work: 1 Publication
Collaboration Details
Page 1 of 6
Previous page
Next page
Grants
(33)
A First In Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Active
·
2023
·
$2.1M
·
External
Principal Investigator (PI)
clinical trials,
oncology,
pharmacokinetics,
safety,
efficacy
A Phase 3, Randomized, Open-label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-cell Lymphoma (DLB
Active
·
2023
·
$1.1M
·
External
Principal Investigator (PI)
lymphoma,
immunotherapy,
clinical trial,
efficacy,
safety
A Phase 1, Multi-center, Open Label First-in-Human Study with ABBV-CLS-579 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors
Active
·
2023
·
$0 / $830.5K
·
External
Co-Investigator (COI)
oncology,
clinical trials,
cancer treatment,
drug development,
immunotherapy
A Phase 1, Multicenter, Open-Label, Dose-Escalation, and Dose-Expansion Study of IO-202 in Combination with Pembrolizumab in Subjects with Advanced, Relapsed, or Refractory Solid Tumors
Active
·
2023
·
$0 / $391.4K
·
External
Co-Investigator (COI)
immunotherapy,
cancer,
clinical trial,
combination therapy,
solid tumors
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors
Active
·
2023
·
$0 / $352.4K
·
External
Co-Investigator (COI)
cancer immunotherapy,
clinical trial,
tumor microenvironment,
intratumoral therapy,
solid tumors
Page 1 of 7
Previous page
Next page
Publications
(1127)
Recent
Selenium uptake and immobilization using indigenous Bacillus strain isolated from seleniferous soils of Punjab
2023
soil contaminants,
bioremediation,
microbial ecology,
selenium,
soil microbiology
The cross-sectional morphology of median nerve in carpal tunnel of healthy, adult population: a systematic review and meta-analysis
2023
median nerve,
carpal tunnel,
morphology,
systematic review,
meta-analysis
Peripheral T-Cell Lymphoma in a Patient Previously Diagnosed With Sarcoidosis
2023
lymphoma,
sarcoidosis,
immune diseases,
cancer,
medical comorbidities
Microsatellite instability in north Indian colorectal cancer patients and its clinicopathological correlation
2022
genetic instability,
colorectal cancer,
clinicopathological correlation,
north indian population,
microsatellite instability
Validation and Evaluation of Plant Growth Promoting Potential of Rhizobacteria Towards Paddy Plants.
2022
plant growth,
rhizobacteria,
paddy plants,
validation,
evaluation
Characterisation of HLA risk alleles in North Indian Multiple Sclerosis
2022
genetic risk factors,
multiple sclerosis,
hla alleles,
population genetics,
autoimmune diseases
A compact fuzzy min max network with novel trimming strategy for pattern classification
2022
fuzzy systems,
pattern recognition,
neural networks,
machine learning,
classification
Minimization of entropy production in the transient thermocapillary flow of hybrid nanoliquid film over a disk
2022
thermocapillary flow,
nanoliquid film,
entropy production,
minimization,
transient behavior
Reduction of Pollution through Sustainable and Flexible Production by Controlling By-Products.
2022
pollution,
sustainable production,
by-products,
flexible production,
controlling
Tisagenlecleucel for secondary CNS lymphoma, a case series.
2022
immunotherapy,
lymphoma,
cns,
cancer treatment